Cargando…
Author Correction: Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice
Autores principales: | Zhang, Jie, Lin, Xiao-Tong, Yu, Hong-Qiang, Fang, Lei, Wu, Di, Luo, Yuan-Deng, Zhang, Yu-Jun, Xie, Chuan-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618234/ https://www.ncbi.nlm.nih.gov/pubmed/37783772 http://dx.doi.org/10.1038/s12276-023-01116-8 |
Ejemplares similares
-
Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice
por: Zhang, Jie, et al.
Publicado: (2023) -
Epigenetic suppression of FBXL7 promotes metastasis
por: Moro, Loredana, et al.
Publicado: (2020) -
Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017) -
Targeting ganglioneuromas with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2021) -
Author Correction: Immunofluorescence can assess the efficacy of mTOR pathway therapeutic agent Everolimus in breast cancer models
por: Kuo, Chun-Ting, et al.
Publicado: (2020)